More

This two day conference is designed for pharmaceutical, biotechnology and medical device companies. Participants will enhance their technical skillset to help them succeed in today's demanding life sciences tax environment.

Even though the rankings shift slightly around the world, the 2013 Top Five Global Employer Rewards Priorities Survey reveals that talent, strategy alignment, and reward costs are on the minds of HR executives everywhere.

This paper describes specific execution measures involving strategy formulation, careful planning, multithreaded execution and an ongoing change management as a means of translating ideas to action, thereby increasing a TRI solution’s usage and making it an invaluable collaborative resource.

Deloitte is pleased to present the life sciences industry’s fourth annual Accounting and Financial Reporting Update. This publication highlights specialized accounting and reporting considerations applicable to companies in this industry.

The story line about health care in 2013 will center on five themes: Clarity, Costs, Compliance, Consolidation, and Consumers.

What’s around the corner for health care organizations and policymakers in 2013? Deloitte’s industry leaders discuss the coming year’s top issues and trends.

Terry Hisey, vice chairman and principal, Deloitte LLP, and U.S. Life Sciences Sector leader, shares his thoughts on the key issues facing the life sciences sector in 2013.

Conducted annually since 2008, Deloitte’s longitudinal study of heath care consumers seeks to provide a comprehensive view of health care consumerism, a view that goes beyond the conventional boundaries of what health and health care are commonly thought to encompass.

This study estimates U.S. health-related spending by taking a broad view of direct and indirect costs as well as items such as alternative medicines, functional foods, and the imputed cost of supervisory care.

Report says mobile apps only scratch the surface of possibilities offered by mHealth. Improvement opportunities exist along the value chain, from engaging patients to maximizing provider productivity to controlling costs.